Jerry B. Lefkowitz

1.2k total citations
17 papers, 940 citations indexed

About

Jerry B. Lefkowitz is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Jerry B. Lefkowitz has authored 17 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Physiology. Recurrent topics in Jerry B. Lefkowitz's work include Blood properties and coagulation (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Jerry B. Lefkowitz is often cited by papers focused on Blood properties and coagulation (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Jerry B. Lefkowitz collaborates with scholars based in United States and Austria. Jerry B. Lefkowitz's co-authors include W Ealding, Charles O. Elson, Xiayuan Liang, Brian Varnum, Susan Sather, Peter M. Henson, Douglas K. Graham, Wolfgang Korte, Rachelle Nuss and Linda Jacobson and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and The Journal of Pediatrics.

In The Last Decade

Jerry B. Lefkowitz

17 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry B. Lefkowitz United States 12 349 233 170 124 108 17 940
Cristina Pascual Spain 16 143 0.4× 320 1.4× 131 0.8× 83 0.7× 98 0.9× 80 980
Pascale E. P. Dekkers Netherlands 16 501 1.4× 358 1.5× 131 0.8× 388 3.1× 168 1.6× 34 1.2k
Mary Ruth Smith United States 16 266 0.8× 133 0.6× 112 0.7× 139 1.1× 96 0.9× 33 887
V J J Bom Netherlands 17 246 0.7× 509 2.2× 276 1.6× 299 2.4× 157 1.5× 30 1.4k
Gun Britt Joø Norway 16 461 1.3× 162 0.7× 79 0.5× 365 2.9× 197 1.8× 23 1.0k
Theodora A. M. Claushuis Netherlands 15 365 1.0× 333 1.4× 102 0.6× 289 2.3× 160 1.5× 21 960
Angela Aggrey United States 7 224 0.6× 344 1.5× 84 0.5× 194 1.6× 140 1.3× 8 1.1k
Uwe Kalina Germany 22 369 1.1× 429 1.8× 150 0.9× 129 1.0× 476 4.4× 41 1.5k
Rachelle P. Davis Canada 10 471 1.3× 134 0.6× 60 0.4× 229 1.8× 252 2.3× 15 865
G. Peer United States 12 245 0.7× 499 2.1× 80 0.5× 320 2.6× 97 0.9× 20 939

Countries citing papers authored by Jerry B. Lefkowitz

Since Specialization
Citations

This map shows the geographic impact of Jerry B. Lefkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry B. Lefkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry B. Lefkowitz more than expected).

Fields of papers citing papers by Jerry B. Lefkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry B. Lefkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry B. Lefkowitz. The network helps show where Jerry B. Lefkowitz may publish in the future.

Co-authorship network of co-authors of Jerry B. Lefkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry B. Lefkowitz. A scholar is included among the top collaborators of Jerry B. Lefkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry B. Lefkowitz. Jerry B. Lefkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cunningham, Mark T., John T. Brandt, Wayne L. Chandler, et al.. (2007). Quality Assurance in Hemostasis: The Perspective from the College of American Pathologists Proficiency Testing Program. Seminars in Thrombosis and Hemostasis. 33(3). 250–258. 26 indexed citations
2.
Hayes, Timothy E., John T. Brandt, Wayne L. Chandler, et al.. (2006). External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing Program. Seminars in Thrombosis and Hemostasis. 32(5). 499–504. 33 indexed citations
3.
Walczak, Steven, Bradley B. Brimhall, & Jerry B. Lefkowitz. (2006). Nonparametric Decision Support Systems in Medical Diagnosis. International Journal of Healthcare Information Systems and Informatics. 1(2). 65–82. 4 indexed citations
4.
Sather, Susan, Jerry B. Lefkowitz, Xiayuan Liang, et al.. (2006). A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood. 109(3). 1026–1033. 256 indexed citations
5.
Lefkowitz, Jerry B., et al.. (2004). False-Positive D-Dimer Result in a Patient With Castleman Disease. Archives of Pathology & Laboratory Medicine. 128(3). 328–331. 11 indexed citations
6.
Sherman, Deb, et al.. (2001). An Institution‐Specific Heparin Titration Nomogram: Development, Validation, and Assessment of Compliance. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(10). 1167–1174. 7 indexed citations
7.
Lefkowitz, Jerry B., et al.. (2001). Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.. PubMed. 936. 129–32. 5 indexed citations
8.
9.
Lefkowitz, Jerry B., et al.. (2001). Fibrinogen Longmont. Annals of the New York Academy of Sciences. 936(1). 129–132. 6 indexed citations
10.
Lefkowitz, Jerry B., Linda Jacobson, A. Weller, et al.. (2000). The prothrombin Denver patient has two different prothrombin point mutations resulting in Glu‐300→Lys and Glu‐309→Lys substitutions. British Journal of Haematology. 108(1). 182–187. 26 indexed citations
11.
Lefkowitz, Jerry B., et al.. (2000). Fibrinogen longmont: A dysfibrinogenemia that causes prolonged clot‐based test results only when using an optical detection method. American Journal of Hematology. 63(3). 149–155. 27 indexed citations
12.
Lefkowitz, Jerry B., et al.. (2000). Unusual complications of warfarin therapy: Skin necrosis and priapism. The Journal of Pediatrics. 137(2). 266–268. 23 indexed citations
13.
Korte, Wolfgang, et al.. (2000). Short Activated Partial Thromboplastin Times Are Related to Increased Thrombin Generation and an Increased Risk for Thromboembolism. American Journal of Clinical Pathology. 113(1). 123–127. 81 indexed citations
14.
Johnson, Marilyn, Rachelle Nuss, Nigel S. Key, et al.. (1996). Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. The Journal of Pediatrics. 128(3). 319–323. 132 indexed citations
15.
Carry, Michael R., et al.. (1995). Diabetic muscle infarction: A new perspective on pathogenesis and management. Neuromuscular Disorders. 5(1). 39–45. 67 indexed citations
16.
Lefkowitz, Jerry B., Dougald M. Monroe, Carol K. Kasper, & Harold R. Roberts. (1993). Comparison of the behavior of normal factor IX and the factor IX BM variant hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources. American Journal of Hematology. 43(3). 177–182. 5 indexed citations
17.
Elson, Charles O., W Ealding, & Jerry B. Lefkowitz. (1984). A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. Journal of Immunological Methods. 67(1). 101–108. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Pascual Breakdown of academic impact, for papers by Pascale E. P. Dekkers Breakdown of academic impact, for papers by Mary Ruth Smith Breakdown of academic impact, for papers by V J J Bom Breakdown of academic impact, for papers by Gun Britt Joø Breakdown of academic impact, for papers by Theodora A. M. Claushuis Breakdown of academic impact, for papers by Angela Aggrey Breakdown of academic impact, for papers by Uwe Kalina Breakdown of academic impact, for papers by Rachelle P. Davis Breakdown of academic impact, for papers by G. Peer
Rankless by CCL
2026